Certified by Founder Lodge
CardioMech AS
Norway - Trondheim
START UP
1 Disclosed Funding Rounds $13,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mitral Regurgitation is the third most common cardiovascular disease that occurs when there is backward flow of blood across the mitral valve. It is highly prevalent, debilitating for patient
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 03 ,2024 | Unknown | $13,000,000 |
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
